IFNA1 and systemic lupus erythematosus: ELISA measurements with an independent cohort of SLE patients with high or low IFN signatures demonstrated that serum IgG reactivity to unmodified and dimethylated forms of the H2B N-terminal tail are associated with dysregulation of IFN signaling.